Introduction 45
Legionella are natural pathogens of unicellular protozoa and accidental pathogens of 46 humans that can cause in a severe inflammatory pneumonia called Legionnaires' Disease, which 47 results from uncontrolled bacterial replication within alveolar macrophages. To replicate within 48 eukaryotic phagocytes, Legionella subvert normal endocytic signaling by establishing a 49 specialized compartment called the Legionella containing vacuole (LCV). To form the LCV and 50 replicate intracellularly, Legionella employ a Dot/Icm type IV secretion system (T4SS) to 51 of L. pneumophila flagellin monomers (flaA) by the NAIP5/NLRC4 inflammasome is sufficient 68 to restrict L. pneumophila replication within macrophages (10, 11). In addition, translocation of 69 peptidoglycan, nucleic acids, and lipopolysaccharide into the host cell cytosol through the 70 Dot/Icm pore also enhances restriction of L. pneumophila. Engagement of both extracellular and 71
intracellular PRRs results in a robust pro-inflammatory response mediated by secretion of 72 cytokines by infected and bystander immune phagocytes (5, (12) (13) (14) (15) (16) . In particular, tumor necrosis 73 factor (TNF) and interferon (IFN)-g are critical for restriction of pulmonary L. pneumophila 74 infection (17-21). TNF and IFN-g both promote cell autonomous defense against L. pneumophila 75 within macrophages and mediate bacterial killing by increasing phagolysosmal fusion (22, 23) . 76
In addition to canonical PAMPs, translocated effectors can augment pro-inflammatory 77 responses in L. pneumophila-infected macrophages. For example, effector-mediated inhibition of 78 host protein translation results in increased expression of pro-inflammatory genes in 79 macrophages (24-27). In addition, macrophage pro-inflammatory gene expression was decreased 80 during infection with Legionella that possess a functional Dot/Icm T4SS but are unable to 81 translocate a subset of effectors due to a mutation in the icmS effector chaperone gene (28) . 82
Lp02 strains were maintained on CYE supplemented with 100 µg mL -1 thymidine. Liquid 114 cultures were grown at 37˚C with aeration in supplemented ACES-buffered yeast extract (AYE) 115 as described (33, 34) . When necessary, media were supplemented with 10 µg mL -1 116 chloramphenicol (plasmid maintenance), 10 µg mL -1 kanamycin (allelic exchange) or 1 mM 117 isopropyl-b-D-1-thiogalactopyranoside (IPTG). 118
Where indicated, recombinant mouse interferon-g (rIFN-g; Thermo Fisher Scientific), 119 recombinant mouse tumor necrosis factor (rTNF; Gibco), rat amouse TNF antibody (a-TNF; 120 R&D Systems), or normal rat IgG control (Rat IgG; R&D Systems) were used at a concentration 121 of 50ng mL -1 . 122
A complete list of oligonucleotide primers used in this study is shown in Table 1 . 123 124 Molecular cloning, plasmid construction and generation of Legionella strains 125
In-frame deletions of legC4 were generated by allelic exchange. Plasmids pSR47s::∆legC4 and 126 pSR47s::∆flaA, gifts from Dr. Craig Roy, were conjugated into SRS43 or Lp02 followed by 127 selection for L. pneumophila deletions as described (35, 36) . Sucrose-resistant, kanamycin-128 sensitive colonies were screened by PCR using legC4KO-up/legC4KO-down and flaAKO-129
Sequence-confirmed pJB1806::plegC4 (pJB::plegC4) and pSN85::legC4 (plegC4) plasmids and 137 empty vectors were transformed into Legionella strains as previous described (39 Bone marrow was harvested from mice as previous described (40). Bone marrow-derived 147 macrophages were generated by differentiation in RPMI supplemented with 20% heat-148 inactivated fetal bovine serum (HI-FBS) (Gibco) and 15% L929 cell supernatant for 6 days prior 149 to seeding for infection. 150
151

Competitive index (CI) experiments in mice 152
Six-to ten-week old age and sex-matched C57BL/6 mice were infected for competitive index 153 experiments as previously described (30). Mixed bacterial inoculums (1:1) were diluted and 154 plated on selective medium (5 µg mL -1 for flaA::Tn and 10 µg mL -1 for plasmid selection). At 48 155 h p.i., mice were euthanized and whole lung tissue was harvested. Lung tissue was homogenized 156 in 300 µL of sterile water using a Bullet Blender (Next Advance) as described (41) LegC4 confers a fitness disadvantage on non-flagellated L. pneumophila in wild-type mice 206
We found previously that the L. pneumophila effector LegC4 is detrimental to bacterial 207 replication in the mouse lung (30). These experiments were performed using mice and 208 macrophages deficient for production of the NLRC4 inflammasome (Nlrc4 -/-) to prevent 209 flagellin-mediated restriction of L. pneumophila replication (10, 30, 42). To confirm that LegC4-210 mediated phenotypes were not due to loss of NLRC4, we examined fitness of a legC4-deficient 211 L. pneumophila (∆legC4) strain in the lungs of wild-type C57BL/6 mice using competitive index 212 (CI) experiments. To prevent NLRC4-mediated restriction of bacterial replication we generated 213 flagellin (flaA) loss-of-function mutations in our wild-type (∆flaA) and legC4 mutant 214 (∆flaA∆legC4) strains (see Materials and Methods). We also used a previously generated 215 flaA::Tn mutant to facilitate selective plating since the transposon confers resistance to 216 chloramphenicol (30). Mice were infected intranasally with a 1:1 mixture of L. pneumophila 217 ∆flaA∆legC4 and flaA::Tn for 48 h. Lung tissue was subsequently homogenized and plated on 218 selective media for CFU enumeration and calculation of CI values (see Materials and Methods). 219
The ∆flaA∆legC4 strain significantly outcompeted the flaA::Tn mutant in the lungs of wild-type 220 mice, as evidenced by average CI values significantly greater than 1.0 (P < 0.01; Fig 1A) . Our 221 previous study also revealed that expression of legC4 from a multi-copy plasmid conferred a 222 fitness disadvantage on L. pneumophila compared to the wild-type strain (30). To confirm these 223 results in wild-type mice, we generated a strain of L. pneumophila ∆flaA∆legC4 harboring a 224 plasmid encoding legC4 under control of its endogenous promoter (pJB::plegC4). Plasmid 225 expression of legC4 (pJB::plegC4) resulted in significantly impaired fitness defect compared 226 with the ∆flaA parental strain, which was not observed for a ∆flaA∆legC4 strain harboring vector alone (pJB) (P<0.05, Fig 1B) . These data demonstrate that NLRC4 does not affect LegC4-228 mediated attenuation of L. pneumophila replication in the mouse lung. To fully evaluate LegC4-229 mediated phenotypes, the remainder of our study was performed using flaA-deficient strains and 230 bone marrow-derived macrophages (BMDMs) derived from wild-type mice. 231 232 Plasmid expression of legC4 attenuates L. pneumophila replication in BMDMs 233
Since plasmid expression of legC4 attenuated L. pneumophila fitness in the mouse lung, 234
we examined whether this also occurred in macrophages ex vivo using BMDMs derived from 235 wild-type mice. We quantified bacterial replication within BMDMs over 72 h. Consistent with 236 our previous study, loss of endogenous legC4 (∆flaA∆legC4) does not affect replication of L. 237 pneumophila within primary mouse BMDMs compared to the parental strain (∆flaA) (30) ( Fig  238   2A ). However, L. pneumophila ∆flaA∆legC4 (pJB::plegC4) was significantly attenuated for 239 replication in BMDMs at 48 and 72 h p.i. compared to the empty vector control strain ( Fig 2B) . 240
Furthermore, IPTG-induced expression of legC4 from a plasmid (plegC4) also resulted in 241 impaired L. pneumophila replication compared to the control strain (pEV) (P<0.01, Fig 2C) . 242
Fitness defects associated with plasmid expression of legC4 were specific to intracellular 243 replication since replication in rich media in vitro was unaffected (data not shown). These data 244 demonstrate that increased levels of LegC4 are detrimental to L. pneumophila intracellular 245 replication in macrophages. 246 production of pro-inflammatory cytokines through engagement of TLRs by bacterial ligands. 251
Indeed, we previously reported that BMDMs infected with L. pneumophila expressing legC4 252 secreted increased levels of interleukin (IL)-12 (30). However, increased levels of IL-12 would 253 likely not be sufficient to attenuate L. pneumophila intracellular replication within BMDMs. Like 254 IL-12, tumor necrosis factor (TNF) is a pro-inflammatory cytokine expressed downstream of 255 toll-like receptors (TLRs) in macrophages. TNF is important for host defense against L. 256 pneumophila in mice and humans and TNF-mediated signaling is sufficient to restrict L. 257 pneumophila intracellular replication within macrophages (17-19, 23, 43). Thus, increased TNF 258 signaling could account for LegC4-mediated attenuation of L. pneumophila intracellular 259
replication. 260
We hypothesized that plasmid expression of legC4 would be sufficient to increase TNF 261 secretion from L. pneumophila-infected BMDMs. Wild-type BMDMs were infected with ∆flaA, 262 ∆flaA∆legC4, ∆flaA∆legC4 (plegC4), or ∆flaA∆legC4 (pEV) for 6 h and secreted TNF was 263 quantified by ELISA (see Materials and Methods). Significantly greater concentrations of TNF 264 were present in the supernatants of cells infected with L. pneumophila expressing legC4 from a 265 plasmid (P<0.01, Fig 3A) . Increased TNF secretion was not due to differences in bacterial 266 replication, since all strains replicated to similar levels at 6 h p.i. (Fig 3B) . We observed the 267 same phenotype following infection with strains constructed in the Lp02 background, which is a 268 thymidine auxotroph (thyA -) that is metabolically active but does not replicate in the absence of 269 exogenous thymidine ( Fig S1) . Thus, overexpression of legC4 results in enhanced TNF secretion 270
To determine if TNF secretion contributed LegC4-mediated attenuation of intracellular L. pneumophila replication within BMDMs associated with LegC4 were observed at 48 h p.i., we 274 quantified fold replication of the indicated strains at this time point (see Materials and Methods). 275
Plasmid expression of legC4 impaired L. pneumophila intracellular replication within wild-type, 276
but not Myd88 -/-, BMDMs ( Fig 3B) . As expected, TNF was not secreted from overexpressing strain to wild-type levels ( Fig 4A) . We subsequently examined replication of 290 these strains in BMDMs deficient for signaling from TNF receptor-1 (TNFR1). Tnfr1 -/-BMDMs 291 were infected with L. pneumophila ∆flaA∆legC4 harboring either plegC4 or pEV and fold 292 replication was quantified at 48 h p.i. As previously observed, over-expression of legC4 impaired 293 intracellular replication within wild-type BMDMs (P<0.05, Fig 4B) . However, there was no 294 difference in fold replication of the legC4-overexpressing strain compared to the empty vector 295 control within Tnfr1 -/-BMDMs ( Fig 4B) . Interestingly, overexpression of legC4 resulted in significantly increased L. pneumophila replication within Tnfr1 -/-BMDMs (P<0.01, Fig 4B) . 297
These data demonstrate that TNF signaling contributes to LegC4-mediated attenuation of L. quantified. We found that overexpression of legC4 significantly attenuated L. pneumophila 318 replication within IFN-g-activated BMDMs (P< 0.05; Fig 5A) . The L. pneumophila ∆flaA∆legC4 mutant replicated to higher levels in IFN-g-activated BMDMs compared to the 320 parental ∆flaA strain (Fig 5B) . Although the replication difference was not statistically 321 significant (P=0.0918), the trend was consistently observed. Together, these data suggest that 322 IFN-g-mediated restriction of L. pneumophila replication is also augmented by LegC4. 323
Macrophage activation by IFN-g results in increased TNF production from macrophages 324 infected with these L. longbeachae strains and fold-replication at 48 h was quantified. 340
Expression of legC4 did not impair L. longbeachae replication within BMDMs; however, legC4 341 expression did result in significantly attenuated L. longbeachae replication within rTNF-and rIFN-g-treated BMDMs compared to the control strain (P<0.001; Fig 6) . These data suggest that 343
LegC4 can augment cytokine-mediated restriction of non-pneumophila Legionella within 344
BMDMs. replication of the ∆flaA strain. However, in the present study, we found that plasmid expression 358 of legC4 was sufficient to attenuate L. pneumophila replication within BMDMs. Although legC4 359 was expressed downstream of its endogenous promoter, an exaggerated phenotype likely 360 occurred due to expression from a multi-copy plasmid, suggesting a potential dose-response. 361
Importantly, this strain provided us with a tool to increase the magnitude of LegC4-mediated 362 fitness attenuation within cultured cells. These phenotypes were corroborated by the observation 363 that endogenous LegC4 was deleterious in cytokine-activated BMDMs. We further found that 364 the fitness disadvantage associated with plasmid expression of legC4 was abolished in macrophages deficient for TNF-mediated signaling, suggesting that LegC4 is able to exacerbate 366 cytokine-mediated antimicrobial responses. Finally, we determined that LegC4 could impair 367 replication of L. longbeachae in cytokine-activated macrophages. Together, these data suggest 368 that LegC4 potentiates cytokine-mediated restriction of L. pneumophila within macrophages. 369
Inflammation is mediated primarily through cytokine secretion, which is critical for 370 restriction of L. pneumophila replication in vivo. This has been evidenced by the inability of 371
Myd88-/-mice to control L. pneumophila replication. Specifically, Myd88-/-BMDMs will not 372 secrete TNF during infection. The inability of plasmid-expressed legC4 to attenuate L. 373 pneumophila replication in Myd88 -/-BMDMs is likely due to lack of TNF signaling. In addition, 374
LegC4-mediated increases in TNF secretion may amplify Tnf expression, which would further 375 restrict L. pneumophila replication. 376
Pro-inflammatory cytokines contribute to host defense against L. pneumophila in vivo 377 and in cultured macrophages (8, 50). Mice deficient for TNF-mediated signaling have increased 378 pulmonary bacterial burdens and can succumb to infection (23, 43). TNF can signal through both 379 TNFR1 and TNFR2; however, TNFR1-mediated signaling is primarily responsible for L. 380 pneumophila restriction within alveolar macrophages in vivo (23) and is potentiated by LegC4. 381
In the lung, multiple cell types contribute to TNF production, a consequence of which would be 382 higher local TNF concentrations (16, 18, 23, 51). In addition, production of IFN-g during L. 383 pneumophila infection in vivo is mediated primarily by circulating natural killer (NK) cells (45, 384 52) . 385
Our observation that the L. pneumophila ∆legC4 mutant had fitness advantage compared 386 to wild-type in the mouse lung but not in cultured macrophages suggested that LegC4 was 387 detrimental to replication under specific environmental conditions. This was supported by the observation that attenuated L. pneumophila replication was correlated with increased TNF 389 secretion from BMDMs. Since the L. pneumophila-infected lung is an inflammatory 390 environment, we examined whether cytokine-mediated restriction was exacerbated by LegC4. 391
Abrogation of signaling from TNFR1 was sufficient to alleviate LegC4-mediated restriction of 392 intracellular replication. Increased replication of the ∆legC4 mutant within rTNF-treated 393
BMDMs strongly suggests that pro-inflammatory responses are exacerbated by LegC4. This 394 conclusion was corroborated by the observation that the ∆legC4 mutant consistently replicated to 395 higher levels within IFN-g-activated macrophages compared to untreated macrophages. In summary, we found that the Dot/Icm effector LegC4 can augment cytokine-mediated 428 restriction of Legionella replication within macrophages. These data add to the growing body of 429 literature on effector triggered immunity in animal cells. As an accidental pathogen that did not 430 co-evolve under the selective pressure of an innate immune system, L. pneumophila continues to 431 provide insight into novel mechanisms of innate immunity towards intracellular bacterial 432 pathogens. Consequently, further understanding of LegC4 function will reveal strategies to 433 augment pro-inflammatory signaling. Thus, this study has provided the foundation for future investigations into the molecular mechanism by which LegC4 enhances host defense against 435 intracellular bacterial pathogens. The funders had no role in study design, data collection and interpretation, or the decision to 444 submit the work for publication. 445 Figure S1 
Figure Legends
